- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2017-001311-36.
Displaying page 1 of 1.
EudraCT Number: 2017-001311-36 | Sponsor Protocol Number: R2810-ONC-16113 | Start Date*: 2018-04-18 |
Sponsor Name:Regeneron Pharmaceuticals, Inc. | ||
Full Title: A Two-Part Randomized, Phase 3 Study of Combinations of Cemiplimab(Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in First-line Treatment of Patients with Advanced or Metastatic Non-Sm... | ||
Medical condition: Non-Small Cell Lung Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Ongoing) GB (GB - no longer in EU/EEA) LT (Completed) IT (Completed) AT (Completed) PL (Ongoing) HR (Ongoing) GR (Ongoing) RO (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.